The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease : How long-term studies contribute to our understandingTASHKIN, Donald P.The American journal of medicine. 2006, Vol 119, Num 10A, issn 0002-9343, S63-S72, SUPArticle

Roflumilast: the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPDTASHKIN, Donald P.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 1, pp 85-96, issn 1465-6566, 12 p.Article

The role of patient-centered outcomes in defining the clinical course of chronic obtructive pulmonary diseaseTASHKIN, Donald P.The American journal of medicine. 2006, Vol 119, Num 10A, issn 0002-9343, 77 p., SUPSerial Issue

Alternative medicine for allergy and asthmaZIMENT, Irwin; TASHKIN, Donald P.Journal of allergy and clinical immunology. 2000, Vol 106, Num 4, pp 603-614, issn 0091-6749Article

Combination of Formoterol and Tiotropium in the Treatment of COPD: Effects on Lung FunctionCAZZOLA, Mario; TASHKIN, Donald P.COPD (Monticello (Sullivan County, N.Y.)). 2009, Vol 6, Num 5, pp 404-415, issn 1541-2555, 12 p.Article

Clinical course of chronic obstructive pulmonary disease : Review of therapeutic interventionsANZUETO, Antonio.The American journal of medicine. 2006, Vol 119, Num 10A, issn 0002-9343, S46-S53, SUPArticle

Evaluation of efficacy and safety of Flunisolide hydrofluoroalkane for the treatment of asthmaCORREN, Jonathan; TASHKIN, Donald P.Clinical therapeutics. 2003, Vol 25, Num 3, pp 776-798, issn 0149-2918, 23 p.Article

Defining Disease Modification in Chronic Obstructive Pulmonary DiseaseHALPIN, David M. G; TASHKIN, Donald P.COPD (Monticello (Sullivan County, N.Y.)). 2009, Vol 6, Num 3, pp 211-225, issn 1541-2555, 15 p.Article

The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progressionWISE, Robert A.The American journal of medicine. 2006, Vol 119, Num 10A, issn 0002-9343, S4-S11, SUPArticle

The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary diseaseNIEWOEHNER, Dennis E.The American journal of medicine. 2006, Vol 119, Num 10A, issn 0002-9343, S38-S45, SUPArticle

The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and functionCOOPER, Christopher B.The American journal of medicine. 2006, Vol 119, Num 10A, issn 0002-9343, S21-S31, SUPArticle

The role of long-acting bronchodilators in the management of stable COPDTASHKIN, Donald P; COOPER, Christopher B.Chest. 2004, Vol 125, Num 1, pp 249-259, issn 0012-3692, 11 p.Article

Smoking cessation in chronic obstructive pulmonary diseaseTASHKIN, Donald P; MURRAY, Robert P.Respiratory medicine. 2009, Vol 103, Num 7, pp 963-974, issn 0954-6111, 12 p.Article

Imaging of the distal airwaysTASHKIN, Donald P; DE LANGE, Eduard E.Journal of allergy and clinical immunology. 2009, Vol 124, Num 6, issn 0091-6749, S78-S83, SUPConference Paper

Impact of chronic obstructive pulmonary disease on quality of life : The role of dyspneaRIES, Andrew L.The American journal of medicine. 2006, Vol 119, Num 10A, issn 0002-9343, S12-S20, SUPArticle

Surrogates of mortality in chronic obstructive pulmonary diseaseCOTE, Claudia G.The American journal of medicine. 2006, Vol 119, Num 10A, issn 0002-9343, S54-S62, SUPArticle

Optimizing treatment of chronic obstructive pulmonary disease : An assessment of current therapiesWISE, Robert A; TASHKIN, Donald P.The American journal of medicine. 2007, Vol 120, Num 8, issn 0002-9343, S4-S13, SUPAConference Paper

Preventing chronic obstructive pulmonary disease : What is known and what needs to be done to make a difference to the patient?WISE, Robert A; TASHKIN, Donald P.The American journal of medicine. 2007, Vol 120, Num 8, issn 0002-9343, S14-S22, SUPAConference Paper

Gender bias in the diagnosis of COPDCHAPMAN, Kenneth R; TASHKIN, Donald P; PYE, David J et al.Chest. 2001, Vol 119, Num 6, pp 1691-1695, issn 0012-3692Article

Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPDTASHKIN, Donald P; PEARLE, James; LEZZONI, Domenic et al.COPD (Monticello (Sullivan County, N.Y.)). 2009, Vol 6, Num 1, pp 17-25, issn 1541-2555, 9 p.Article

Compliance with bronchodilator treatmentMALOZOWSKI, Saul; KOLLER, Elizabeth; SIMMONS, Michael S et al.Chest. 2001, Vol 119, Num 3, pp 988-989, issn 0012-3692Article

Marijuana smoke and Δ⁹-tetrahydrocannabinol promote necrotic cell death but inhibit Fas-mediated apoptosisSARAFIAN, Theodore A; TASHKIN, Donald P; ROTH, Michael D et al.Toxicology and applied pharmacology. 2001, Vol 174, Num 3, pp 264-272, issn 0041-008XArticle

Δ⁹-Tetrahydrocannabinol disrupts mitochondrial function and cell energeticsSARAFIAN, Theodore A; KOUYOUMJIAN, Shaghig; KHOSHAGHIDEH, Farnaz et al.American journal of physiology. Lung cellular and molecular physiology. 2003, Vol 28, Num 2, pp L298-L306, issn 1040-0605Article

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialDECRAMER, Marc; CELLI, Bartolome; KESTEN, Steven et al.Lancet (British edition). 2009, Vol 374, Num 9696, pp 1171-1178, issn 0140-6736, 8 p.Article

Skin manifestations of inhaled corticosteroids in COPD patients: Results from Lung Health Study IITASHKIN, Donald P; MURRAY, H. Eileen; SKEANS, Melissa et al.Chest. 2004, Vol 126, Num 4, pp 1123-1133, issn 0012-3692, 11 p.Article